Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796518 · ClinicalTrials.gov registry record · NA
Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT05796518: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT05796518 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05796518, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.
Primary Outcome
Feasibility will be defined from the number of participants who complete the web-based assessment using exact 95% binomial confidence intervals.
Interventions
- OTHER Survey
- OTHER PREVENT Cardiovascular Health Assessment Tool
- OTHER Interview Regarding Heart Health
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-09-07 |
| Est. Completion | 2024-06-07 |
| Phase | NA |
What the finished NCT05796518 record still lists
NCT05796518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Survey is the first listed.
NCT05796518 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05796518 about?
NCT05796518 is a clinical study titled "Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors". Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health o...
What is the current status of trial NCT05796518?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2023-09-07. Estimated completion is 2024-06-07.
What interventions are being tested in trial NCT05796518?
The interventions under investigation include: Survey (OTHER), PREVENT Cardiovascular Health Assessment Tool (OTHER), Interview Regarding Heart Health (OTHER).
Who is sponsoring clinical trial NCT05796518?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05796518's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI